United States · Research
Research
Biostate AI is a healthcare startup based in Palo Alto, founded in 2023. The company specializes in generative AI-driven predictive omics analytics, focusing on scalable and cost-effective multiomic data collection and analysis. Biostate AI aims to advance scientific discovery and AI training in human health. The company operates as a scalable biodata foundry, combining advanced RNA sequencing with AI-powered analytics. Its offerings include Total RNA Sequencing using patent-pending BIRT Technology, which analyzes all RNA types, and an AI-driven platform called Copilot for RNAseq Data Analysis that provides free data analysis alongside sequencing services. Biostate AI also integrates RNA sequencing with DNA methylation and proteomics analysis to predict future biological states. Biostate AI targets academic researchers, pharmaceutical and biotech firms, and hospital biorepositories, positioning itself as a partner for organizations focused on scalable biodata infrastructure and AI-driven health predictions.
2023
Founded
Research
Industry
United States
Location
7,222,928
Ranking
38 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
